Loading...

Kathleen Wilson-Edell, PhD

TitleLicensing Associate
SchoolUCSF Chancellor/EVC/FAS
DepartmentVice Chanc Research
Address600 16th St
San Francisco CA 94158
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Cornell UniversityA.B.2004Biology
    Yale UniversityPh.D.2009Genetics

    Collapse Overview 
    Collapse Overview
    Kathy joined the UCSF Office of Innovation, Technology & Alliances (ITA) in March of 2014. She works with UCSF faculty members to protect intellectual property arising from their research and negotiates licenses to these technologies with both startups and established companies.

    Prior to joining ITA full-time, Kathy was a part-time Technology Analyst with UCSF ITA while completing her postdoctoral training at the Buck Institute for Research on Aging in Dr. Christopher Benz’s laboratory. Her postdoctoral research focused on the role of ribosomal proteins in breast cancer. She received her Ph.D. in Genetics from Yale University in Dr. David Stern’s laboratory, studying regulation of gene expression and cytoskeleton rearrangement by BRCA1-related proteins. Kathy’s A.B. is from Cornell University, where she was a Presidential Research Scholar.

    Kathy is passionate about helping UCSF investigators move their discoveries from the laboratory to the public domain.


    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Laberge RM, Sun Y, Orjalo AV, Patil CK, Freund A, Zhou L, Curran SC, Davalos AR, Wilson-Edell K, Liu S, Limbad C, Demaria M, Li P, Hubbard GB, Ikeno Y, Javors M, Desprez PY, Benz CC, Kapahi P, Nelson PS, Campisi J. MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation. Nat Cell Biol. 2015 Aug; 17(8):1049-61. PMID: 26147250.
      View in: PubMed
    2. Wilson-Edell K, Kehasse A, Scott GK, Yau C, Rothschild DE, Schilling B, Gabriel BS, Yevtushenko MA, Hanson IM, Held JM, Gibson BW, Benz CC. RPL24: a potential therapeutic target whose depletion or acetylation inhibits polysome assembly and cancer cell growth. Oncotarget. 2014 Jul 15; 5(13):5165-76. PMID: 24970821; PMCID: PMC4148130.
    3. Wilson KA, Colavito SA, Schulz V, Wakefield PH, Sessa W, Tuck D, Stern DF. NFBD1/MDC1 regulates Cav1 and Cav2 independently of DNA damage and p53. Mol Cancer Res. 2011 Jun; 9(6):766-81. PMID: 21551225; PMCID: PMC3901581.
    4. Wilson KA, Stern DF. NFBD1/MDC1, 53BP1 and BRCA1 have both redundant and unique roles in the ATM pathway. Cell Cycle. 2008 Nov 15; 7(22):3584-94. PMID: 19001859; PMCID: PMC2763172.
    5. Qian J, Morley S, Wilson K, Nava P, Atkinson J, Manor D. Intracellular trafficking of vitamin E in hepatocytes: the role of tocopherol transfer protein. J Lipid Res. 2005 Oct; 46(10):2072-82. PMID: 16024914.
      View in: PubMed
    6. Qian J, Wilson K, Nava P, Morley S, Atkinson J, Manor D. Intracellular localization of alpha-tocopherol transfer protein and alpha-tocopherol. Ann N Y Acad Sci. 2004 Dec; 1031:330-1. PMID: 15753160.
      View in: PubMed
    7. Barnaby NG, He F, Liu X, Wilson KA, Wilson KA, Tan-Wilson A. Light-responsive subtilisin-related protease in soybean seedling leaves. Plant Physiol Biochem. 2004 Feb; 42(2):125-34. PMID: 15283128.
      View in: PubMed
    Kathleen's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP